These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 11163861)

  • 1. Possible association of thioredoxin and p53 in breast cancer.
    Ueno M; Matsutani Y; Nakamura H; Masutani H; Yagi M; Yamashiro H; Kato H; Inamoto T; Yamauchi A; Takahashi R; Yamaoka Y; Yodoi J
    Immunol Lett; 2000 Dec; 75(1):15-20. PubMed ID: 11163861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thioredoxin-dependent redox regulation of p53-mediated p21 activation.
    Ueno M; Masutani H; Arai RJ; Yamauchi A; Hirota K; Sakai T; Inamoto T; Yamaoka Y; Yodoi J; Nikaido T
    J Biol Chem; 1999 Dec; 274(50):35809-15. PubMed ID: 10585464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inverse correlation of thioredoxin expression with estrogen receptor- and p53-dependent tumor growth in breast cancer tissues.
    Matsutani Y; Yamauchi A; Takahashi R; Ueno M; Yoshikawa K; Honda K; Nakamura H; Kato H; Kodama H; Inamoto T; Yodoi J; Yamaoka Y
    Clin Cancer Res; 2001 Nov; 7(11):3430-6. PubMed ID: 11705859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear thioredoxin-1 is required to suppress cisplatin-mediated apoptosis of MCF-7 cells.
    Chen XP; Liu S; Tang WX; Chen ZW
    Biochem Biophys Res Commun; 2007 Sep; 361(2):362-6. PubMed ID: 17651689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous thioredoxin is required for redox cycling of anthracyclines and p53-dependent apoptosis in cancer cells.
    Ravi D; Muniyappa H; Das KC
    J Biol Chem; 2005 Dec; 280(48):40084-96. PubMed ID: 16159878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Widespread expression of thioredoxin and thioredoxin reductase in non-small cell lung carcinoma.
    Soini Y; Kahlos K; Näpänkangas U; Kaarteenaho-Wiik R; Säily M; Koistinen P; Pääakkö P; Holmgren A; Kinnula VL
    Clin Cancer Res; 2001 Jun; 7(6):1750-7. PubMed ID: 11410516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased thioredoxin-1 inhibits SSAT expression in MCF-7 human breast cancer cells.
    Husbeck B; Stringer DE; Gerner EW; Powis G
    Biochem Biophys Res Commun; 2003 Jun; 306(2):469-75. PubMed ID: 12804587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thioredoxin inhibits MPK38-induced ASK1, TGF-β, and p53 function in a phosphorylation-dependent manner.
    Manoharan R; Seong HA; Ha H
    Free Radic Biol Med; 2013 Oct; 63():313-24. PubMed ID: 23747528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specificity of seven monoclonal antibodies against p53 evaluated with Western blotting, immunohistochemistry, confocal laser scanning microscopy, and flow cytometry.
    Bonsing BA; Corver WE; Gorsira MC; van Vliet M; Oud PS; Cornelisse CJ; Fleuren GJ
    Cytometry; 1997 May; 28(1):11-24. PubMed ID: 9136751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up-regulation of thioredoxin and thioredoxin reductase in human malignant pleural mesothelioma.
    Kahlos K; Soini Y; Säily M; Koistinen P; Kakko S; Pääkkö P; Holmgren A; Kinnula VL
    Int J Cancer; 2001 May; 95(3):198-204. PubMed ID: 11307155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of thioredoxin/adult T-cell leukemia-derived factor in cisplatin-resistant human cancer cell lines.
    Yamada M; Tomida A; Yoshikawa H; Taketani Y; Tsuruo T
    Clin Cancer Res; 1996 Feb; 2(2):427-32. PubMed ID: 9816187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of p53 dependent gene expression and cell death through thioredoxin-thioredoxin reductase by the Interferon-Retinoid combination.
    Hu J; Ma X; Lindner DJ; Karra S; Hofmann ER; Reddy SP; Kalvakolanu DV
    Oncogene; 2001 Jul; 20(31):4235-48. PubMed ID: 11464290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The redox protein thioredoxin-1 regulates the constitutive and inducible expression of the estrogen metabolizing cytochromes P450 1B1 and 1A1 in MCF-7 human breast cancer cells.
    Husbeck B; Powis G
    Carcinogenesis; 2002 Oct; 23(10):1625-30. PubMed ID: 12376470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural state of mutant p53 protein and heat shock protein 70 in breast cancer tissues.
    Iwaya K; Tsuda H; Fujita S; Suzuki M; Hirohashi S
    Lab Invest; 1995 Jun; 72(6):707-14. PubMed ID: 7540234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the inhibition of mammalian thioredoxin, thioredoxin reductase, and glutaredoxin by cis-diamminedichloroplatinum (II) and its major metabolite, the glutathione-platinum complex.
    Arnér ES; Nakamura H; Sasada T; Yodoi J; Holmgren A; Spyrou G
    Free Radic Biol Med; 2001 Nov; 31(10):1170-8. PubMed ID: 11705695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative splicing is associated with decreased expression of the redox proto-oncogene thioredoxin-1 in human cancers.
    Berggren MM; Powis G
    Arch Biochem Biophys; 2001 May; 389(1):144-9. PubMed ID: 11370665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CLDN6 promotes chemoresistance through GSTP1 in human breast cancer.
    Yang M; Li Y; Shen X; Ruan Y; Lu Y; Jin X; Song P; Guo Y; Zhang X; Qu H; Shao Y; Quan C
    J Exp Clin Cancer Res; 2017 Nov; 36(1):157. PubMed ID: 29116019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High thioredoxin expression is associated with resistance to docetaxel in primary breast cancer.
    Kim SJ; Miyoshi Y; Taguchi T; Tamaki Y; Nakamura H; Yodoi J; Kato K; Noguchi S
    Clin Cancer Res; 2005 Dec; 11(23):8425-30. PubMed ID: 16322305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear factor kappaB transactivation is increased but is not involved in the proliferative effects of thioredoxin overexpression in MCF-7 breast cancer cells.
    Freemerman AJ; Gallegos A; Powis G
    Cancer Res; 1999 Aug; 59(16):4090-4. PubMed ID: 10463612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The redox protein thioredoxin-1 (Trx-1) increases hypoxia-inducible factor 1alpha protein expression: Trx-1 overexpression results in increased vascular endothelial growth factor production and enhanced tumor angiogenesis.
    Welsh SJ; Bellamy WT; Briehl MM; Powis G
    Cancer Res; 2002 Sep; 62(17):5089-95. PubMed ID: 12208766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.